| Dengue NS1 antigen as a marker of severe clinical disease SA Paranavitane, L Gomes, A Kamaladasa, TN Adikari, ... BMC infectious diseases 14, 1-7, 2014 | 125 | 2014 |
| Dengue NS1 antigen contributes to disease severity by inducing interleukin (IL)-10 by monocytes TN Adikari, L Gomes, N Wickramasinghe, M Salimi, N Wijesiriwardana, ... Clinical & Experimental Immunology 184 (1), 90-100, 2016 | 80 | 2016 |
| Suppression of virus specific immune responses by IL-10 in acute dengue infection GN Malavige, C Jeewandara, KML Alles, M Salimi, L Gomes, ... PLoS neglected tropical diseases 7 (9), e2409, 2013 | 64 | 2013 |
| Immune responses to a single dose of the AZD1222/Covishield vaccine in health care workers C Jeewandara, A Kamaladasa, PD Pushpakumara, D Jayathilaka, ... Nature Communications 12 (1), 4617, 2021 | 39 | 2021 |
| Lipopolysaccharide acts synergistically with the dengue virus to induce monocyte production of platelet activating factor and other inflammatory mediators A Kamaladasa, L Gomes, C Jeewandara, NLA Shyamali, GS Ogg, ... Antiviral research 133, 183-190, 2016 | 38 | 2016 |
| Functionality of dengue virus specific memory T cell responses in individuals who were hospitalized or who had mild or subclinical dengue infection C Jeewandara, TN Adikari, L Gomes, S Fernando, RH Fernando, ... PLoS neglected tropical diseases 9 (4), e0003673, 2015 | 35 | 2015 |
| Regulatory T‐cells in acute dengue viral infection HE Jayaratne, D Wijeratne, S Fernando, A Kamaladasa, L Gomes, ... Immunology 154 (1), 89-97, 2018 | 31 | 2018 |
| Antibody and T cell responses to Sinopharm/BBIBP-CorV in naïve and previously infected individuals in Sri Lanka C Jeewandara, IS Aberathna, PD Pushpakumara, A Kamaladasa, ... MedRxiv, 2021.07. 15.21260621, 2021 | 30 | 2021 |
| Persistence of immune responses to the Sinopharm/BBIBP‐CorV vaccine C Jeewandara, IS Aberathna, PD Pushpakumara, A Kamaladasa, ... Immunity, inflammation and disease 10 (6), e621, 2022 | 25 | 2022 |
| Persistence of antibody and T cell responses to the Sinopharm/BBIBP-CorV vaccine in Sri Lankan individuals C Jeewandara, IS Aberathna, PD Pushpakumara, A Kamaladasa, ... MedRxiv, 2021.10. 14.21265030, 2021 | 25 | 2021 |
| Antibody and T cell responses to Sinopharm C Jeewandara, IS Aberathna, PD Pushpakumara, A Kamaladasa, ... BBIBP-CorV in naïve and previously infected individuals in Sri Lanka …, 2021 | 17 | 2021 |
| Comparison of two assays to detect IgG antibodies to the receptor binding domain of SARS‑CoV‑2 as a surrogate marker for assessing neutralizing antibodies in COVID-19 patients A Kamaladasa, B Gunasekara, C Jeewandara, D Jayathilaka, ... International Journal of Infectious Diseases 109, 85-89, 2021 | 17 | 2021 |
| Comparison of the immunogenicity of five COVID‐19 vaccines in Sri Lanka C Jeewandara, IS Aberathna, S Danasekara, L Gomes, S Fernando, ... Immunology 167 (2), 263-274, 2022 | 14 | 2022 |
| Dengue virus co-opts innate type 2 pathways to escape early control of viral replication CL Fonseka, CS Hardman, J Woo, R Singh, J Nahler, J Yang, YL Chen, ... Communications Biology 5 (1), 735, 2022 | 10 | 2022 |
| Altered monocyte response to the dengue virus in those with varying severity of past dengue infection A Kamaladasa, L Gomes, A Wijesinghe, C Jeewandara, YX Toh, ... Antiviral research 169, 104554, 2019 | 10 | 2019 |
| Kinetics of immune responses to the AZD1222/Covishield vaccine with varying dose intervals in Sri Lankan individuals C Jeewandara, IS Aberathna, L Gomes, PD Pushpakumara, ... Immunity, Inflammation and Disease 10 (4), e592, 2022 | 9 | 2022 |
| Immune responses following the first dose of the Sputnik V (Gam-COVID-Vac) C Jeewandara, S Fernando, PD Pushpakumara, ST Ramu, ... Scientific Reports 12 (1), 1727, 2022 | 9 | 2022 |
| Antibody and T cell responses to a single dose of the AZD1222/Covishield vaccine in previously SARS-CoV-2 infected and naïve health care workers in Sri Lanka C Jeewandara, A Kamaladasa, PD Pushpakumara, D Jayathilaka, ... medRxiv, 2021.04. 09.21255194, 2021 | 9 | 2021 |
| Immune responses to Sinopharm/BBIBP‐CorV in individuals in Sri Lanka C Jeewandara, IS Aberathna, PD Pushpakumara, A Kamaladasa, ... Immunology 167 (2), 275-285, 2022 | 8 | 2022 |
| Expansion of highly activated invariant natural killer T cells with altered phenotype in acute dengue infection A Kamaladasa, N Wickramasinghe, TN Adikari, L Gomes, NLA Shyamali, ... Clinical & Experimental Immunology 185 (2), 228-238, 2016 | 6 | 2016 |
